Yang TJ, Yang TS, Liang HM. Thalidomide and congenital abnormalities. Lancet. 1963;1(7280):552–3.
Article
CAS
PubMed
Google Scholar
Webster WS, Freeman JAD. Prescription drugs and pregnancy. Expert Opin Pharmacother. 2003;4(6):949–61.
Article
PubMed
Google Scholar
Ayad M, Costantine MM. Epidemiology of medications use in pregnancy. Semin Perinatol. 2015;39(7):508–11.
Article
PubMed
PubMed Central
Google Scholar
Sannerstedt R, Lundborg P, Danielsson BR, Kihlström I, Alván G, Prame B, et al. Drugs during pregnancy: an issue of risk classification and information to prescribers. Drug Saf. 1996;14(2):69–77.
Article
CAS
PubMed
Google Scholar
Ritchie H, Bolton P. The Australian categorisation of risk of drug use in pregnancy. Aust Fam Physician. 2000;29(3):237–41.
CAS
PubMed
Google Scholar
Addis A, Sharabi S, Bonati M. Risk classification systems for drug use during pregnancy - are they a reliable source of information? Drug Saf. 2000;23(3):245–53.
Article
CAS
PubMed
Google Scholar
Briggs GG, Freeman RK, Towers CV, Forinash AB. Drugs in pregnancy and lactation. 11th ed: Philadelphia: Wolters Kluwer; 2017.
National Archives and Records Administration. Federal Register: 44 Fed. Reg. 37434 (June 26, 1979). Labeling and Prescription Drug Advertising; Content and Format for Labeling for Human Prescription Drugs; 1979. p. 282–5.
Google Scholar
Doering PL, Boothby LA, Cheok M. Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks? Am J Obstet Gynecol. 2002;187(2):333–9.
Article
PubMed
Google Scholar
Bedewi N, Sisay M, Edessa D. Drug utilization pattern among pregnant women attending maternal and child health clinic of tertiary hospital in eastern Ethiopia: consideration of toxicological perspectives. BMC Res Notes. 2018;11(1):858.
Article
PubMed
PubMed Central
Google Scholar
Zomerdijk IM, Ruiter R, Houweling LM, Herings RM, Straus SM, Stricker BH. Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study. BJOG. 2015;122(8):1119–29.
Article
CAS
PubMed
Google Scholar
Dhar M, Komaram RB. Assessment of drug utilization pattern and teratogenicity risk among pregnant women attending a tertiary care hospital, Andhra Pradesh. Int J Pharm Sci Res. 2017;8(12):5291–7.
Google Scholar
Molla F, Assen A, Abrha S, Masresha B, Gashaw A, Wondimu A, et al. Prescription drug use during pregnancy in southern Tigray region, North Ethiopia. BMC Pregnancy Childbirth. 2017;17:6.
Article
Google Scholar
Tronnes JN, Lupattelli A, Nordeng H. Safety profile of medication used during pregnancy: results of a multinational European study. Pharmacoepidemiol Drug Saf. 2017;26(7):802–11.
Article
PubMed
PubMed Central
Google Scholar
Rouamba T, Valea I, Bognini JD, Kpoda H, Mens PF, Gomes MF, et al. Safety profile of drug use during pregnancy at peripheral health Centres in Burkina Faso: a prospective observational cohort study. Drugs Real World Outcomes. 2018;5(3):193–206.
Article
PubMed
PubMed Central
Google Scholar
Hardy JR, Leaderer BP, Holford TR, Hall GC, Bracken MB. Safety of medications prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK general Practice research database. Pharmacoepidemiol Drug Saf. 2006;15(8):555–64.
Article
PubMed
Google Scholar
Lee E, Maneno MK, Smith L, Weiss SR, Zuckerman IH, Wutoh AK, et al. National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf. 2006;15(8):537–45.
Article
PubMed
Google Scholar
Cleary BJ, Butt H, Strawbridge JD, Bsc PJG, Fahey T, Murphy DJ. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol Drug Saf. 2010;19(4):408–17.
PubMed
Google Scholar
Odalovic M, Kovacevic SV, Ilic K, Sabo A, Tasic L. Drug use before and during pregnancy in Serbia. Int J Clin Pharm. 2012;34(5):719–27.
Article
PubMed
Google Scholar
Yang TB, Walker MC, Krewski D, Yang QY, Nimrod C, Garner P, et al. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population. Pharmacoepidemiol Drug Saf. 2008;17(3):270–7.
Article
PubMed
Google Scholar
Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). Clin Ther. 2012;34(1):239–49.
Article
PubMed
Google Scholar
National Health Commission of the People’s Republic of China. Statistical bulletin on medical and health development in 2017: National Health Commission of the People’s Republic of China; 2018. http://www.moh.gov.cn/guihuaxxs/s10743/201806/44e3cdfe11fa4c7f928c879d435b6a18.shtml
Zeng Y, Hesketh T. The effects of China's universal two-child policy. Lancet. 2016;388(10054):1930–8.
Article
PubMed
PubMed Central
Google Scholar
Li H-T, Xue M, Hellerstein S, Cai Y, Gao Y, Zhang Y, et al. Association of China's universal two child policy with changes in births and birth related health factors: national, descriptive comparative study. BMJ (Clin Res ed). 2019;366:l4680–l.
Google Scholar
Frederiksen LE, Ernst A, Brix N, Braskhoj Lauridsen LL, Roos L, Ramlau-Hansen CH, et al. Risk of adverse pregnancy outcomes at advanced maternal age. Obstet Gynecol. 2018;131(3):457–63.
Article
PubMed
Google Scholar
the State Council Information Office of the People’s Republic of China. The right to development: China's philosophy, Practice and contribution. 1st ed. Beijing: Foreign Languages Press; 2016.
Google Scholar
Xia L, Li J-H, Zhao K, Wu H-Y. Incidence and in-hospital mortality of acute aortic dissection in China: analysis of China health insurance research (CHIRA) data 2011. J Geriatr Cardiol. 2015;12(5):502–6.
PubMed Central
PubMed
Google Scholar
Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA, et al. Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf. 2013;22(5):524–32.
Article
PubMed
PubMed Central
Google Scholar
Gerald G, Briggs RKF, Towers CV, Forinash AB. Drugs in Pregnancy and Lactation: Eleventh Edition: Wolters Kluwer; 2017.
Google Scholar
Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernandez-Diaz S, et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011;205(1):8.
Article
Google Scholar
Lupattelli A, Spigset O, Twigg MJ, Zagorodnikova K, Mardby AC, Moretti ME, et al. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4(2):11.
Article
Google Scholar
Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191(2):398–407.
Article
PubMed
Google Scholar
Yang T, Walker MC, Krewski D, Yang Q, Nimrod C, Garner P, et al. Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population. Pharmacoepidemiol Drug Saf. 2008;17(3):270–7.
Article
PubMed
Google Scholar
Wen SW, Yang T, Krewski D, Yang Q, Nimrod C, Garner P, et al. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population. J Perinatol. 2008;28(5):324–9.
Article
CAS
PubMed
Google Scholar
Malm H, Martikainen J, Klaukka T, Neuvonen PJ. Prescription of hazardous drugs during pregnancy. Drug Saf. 2004;27(12):899–908.
Article
PubMed
Google Scholar
Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313(14):837–41.
Article
CAS
PubMed
Google Scholar
De Santis M, Straface G, Cavaliere A, Nobili E, Caruso A. The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity. Prev Med. 2007;45(2):243–4.
Article
PubMed
Google Scholar
Rubin PC. Prescribing in pregnancy. General principles. Br Med J (Clin Res Ed). 1986;293(6559):1415–7.
Article
CAS
Google Scholar
Sørensen HT, Nielsen GL, Andersen AMN, Zhou WJ, Steffensen FH, Olesen C, et al. Drug use in pregnancy. Principal problems and a review of newer utilization studies. Clin Res Regul Aff. 1996;13(3–4):181–97.
Article
Google Scholar
Spera AM, Eldin TK, Tosone G, Orlando R. Antiviral therapy for hepatitis C: has anything changed for pregnant/lactating women? World J Hepatol. 2016;8(12):557–65.
Article
PubMed
PubMed Central
Google Scholar
Snell NJC. New treatments for viral respiratory tract infections—opportunities and problems. J Antimicrob Chemother. 2001;47(3):251–9.
Article
CAS
PubMed
Google Scholar
Ghulmiyyah LM, Alame MM, Mirza FG, Zaraket H, Nassar AH. Influenza and its treatment during pregnancy: a review. J Neonatal-Perinatal Med. 2015;8(4):297–306.
Article
CAS
PubMed
Google Scholar
ACOG Practice Bulletin No. 87: Use of Psychiatric Medications During Pregnancy and Lactation. Obstet Gynecol. 2007;110(5):1179–98.
Donati S, Baglio G, Spinelli A, Grandolfo ME. Drug use in pregnancy among Italian women. Eur J Clin Pharmacol. 2000;56(4):323–8.
Article
CAS
PubMed
Google Scholar
Refuerzo JS, Blackwell SC, Sokol RJ, Lajeunesse L, Firchau K, Kruger M, et al. Use of over-the-counter medications and herbal remedies in pregnancy. Am J Perinatol. 2005;22(6):321–4.
Article
PubMed
Google Scholar
Odalovic M, Kovacevic SV, Nordeng H, Ilic K, Sabo A, Tasic L. Predictors of the use of medications before and during pregnancy. Int J Clin Pharm. 2013;35(3):408–16.
Article
PubMed
Google Scholar
Raebel MA, Ellis JL, Andrade SE. Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data. Pharmacoepidemiol Drug Saf. 2005;14(12):829–36.
Article
PubMed
Google Scholar